Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIW-8962 in advanced lung cancer or mesothelioma
NCT01898156Phase 2Terminated
- Sponsor
- Kyowa Kirin
- Start
- Jul 2013
- Primary completion
- Jun 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of biw-8962 in non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), mesothelioma, sponsored by Kyowa Kirin. Started Jul 2013; status: terminated.
02
Drugs
biw-8962
03
Conditions
non-small cell lung cancer (NSCLC)small cell lung cancer (SCLC)mesothelioma
Beyond the preview
Go deeper on NCT01898156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898156.